# High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/high-and-low-dose-interferon-alfa-2b-in-high-risk-melanoma-first-analysis-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John M. Kirkwood,Joseph G. Ibrahim,Vernon K. Sondak,Jon Richards,Lawrence E. Flaherty,Marc S. Ernstoff,Thomas J. Smith,Uma Rao,Mary Steele,Ronald H. Blum |
| Citations | 923 |
| DOI | 10.1200/jco.2000.18.12.2444 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1908752382 |
| PMID | 10856105 |
| Type | article |
| Year | 2000 |

## Paper authors

- [Thomas J. Smith](https://scholariq.org/researchers/thomas-j-smith/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Paper topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.